Author | Melissa A. Wilson, MD, PhD | OncLive

Author | Melissa A. Wilson, MD, PhD

Articles

Dr. Wilson on Choosing Between BRAF/MEK Therapies for Patients With Melanoma

August 16, 2017

Video

Melissa A. Wilson, MD, PhD, an assistant professor of medicine at Perlmutter Cancer Center at NYU Langone Medical Center, discusses how physicians select between the 2 BRAF/MEK inhibitor combination regimens for their patients with melanoma.

Dr. Wilson on Long-term Data With Dabrafenib Plus Trametinib in Melanoma

July 27, 2017

Video

Melissa A. Wilson, MD, PhD, an assistant professor of medicine at Perlmutter Cancer Center at NYU Langone Medical Center, discusses the long-term data with the combination of dabrafenib (Tafinlar) and trametinib (Mekinist) in patients with BRAF-mutant melanoma.

Targeted Therapies, Combination Protocols Are Revolutionizing Treatment for Advanced Melanoma

July 14, 2015

Article

Melissa A. Wilson, MD, PhD, discusses how targeted therapies and combination protocols are revolutionizing the treatment paradigm of advanced melanoma.

x